| This week's sponsor is Premier Research. | | | >From Lab to Bedside: The Latest Rare Oncology Drug Research
Study of rare cancers demands immersion in dual indications where strategies often don't mesh. Attend our Feb. 28 webinar for fresh insights on speeding development of new drugs. Register now. Premier Research. It's what we do. Best. |
Top Stories Monday, February 6, 2017 A phase 2 trial of Innate Pharma’s lirilumab in elderly patients with acute myeloid leukemia (AML) has missed its primary endpoint. The Bristol-Myers Squibb-partnered checkpoint inhibitor failed to improve leukemia-free survival by more than placebo. Monday, February 6, 2017 Chondrial Therapeutics has secured a near $23 million raise, led by VC Deerfield Management, and has taken on Deerfield’s adviser Carole Ben-Maimon as its new president and CEO. Monday, February 6, 2017 Belgian biotech Ablynx has filed its first-ever marketing application, seeking EU approval for its new drug for an ultrarare blood clotting disorder. Monday, February 6, 2017 Medical testing company LabCorp is prepared to spend $8 billion on one of the largest CROs in the world, coming hot on the heels of it buying up New Jersey-headquartered Covance in an acquisition worth just over $6 billion in 2015. Monday, February 6, 2017 Pharma companies sat out the Super Bowl this year after last year’s intense scrutiny—and criticism—of three ads that aired. But their DTC devices did make one appearance. | | | Strata Oncology will work with Epizyme to help support trials of its troubled blood cancer med tazemetostat. Release BioTime has boosted its ophthalmology portfolio with a licensing deal for a next-gen retinal disease med out of the University of Pittsburgh Medical Center. Statement Amid the $5.2 billion buyout deal from Takeda, Ariad said it has submitted an app to the EMA for its blood cancer candidate brigatinib. Release | |
|
Resources Sponsored By: Veeva Learn over a dozen best practices for deploying a global content system. Read Whitepaper. Sponsored By: Veeva Gartner provides insightful research on preparing for IDMP compliance. Read Whitepaper. Sponsored By: Veeva Learn How to Create a Unified RIM Environment for IDMP. Find out. Sponsored By: Veeva The largest survey of TMF owners reveals drivers and trends in improving inspection readiness and shortening trial time. Sponsored By: Salesforce Learn how the healthcare and life science industry is using agile application development to drive innovation and accelerate their business with the Salesforce Platform. Presented by: Patheon Can you avoid a risky trial-and-error approach to find the right path for your poorly soluble molecule by utilizing a CDMO? Download this complimentary Whitepaper to learn more! CBI’s Abuse Deterrent Formulations Summit March 7-8, 2017 | Alexandria, VA PEGS: The Essential Protein Engineering Summit May 1-5, 2017 | Boston, MA Drug Development Boot Camp® 2017 November 15-16, 2017 | Boston, MA BIO CEO & Investor Conference February 13 – 14, 2017 | The Waldorf Astoria, New York, NY |
